Inline Degasser for High Flow Rate Applications
Biotech Fluidics announces DEGASi Prep+, the world’s first in-line membrane degasser ready to use at 150 mL/minute with aggressive media and organic solvents.
Efficient Transduction of CAR Into T Cells
AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells.
Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium To Accelerate Cell Therapy Development
Lonza has launched the TheraPEAK® T-VIVO® Cell Culture Medium, a novel chemically defined medium developed to optimize CAR T-cell manufacture.
Autoscribe Expands Into Egypt Appointing Labtec Egypt Group as a Distributor
Autoscribe Informatics has appointed Labtec Egypt Group (LEG) as its distributor for the Matrix Gemini Laboratory Information Management System (LIMS) in Egypt.
Beckman Coulter Launches the Only Immunoassay Analyzer With No Daily Maintenance
Beckman Coulter today unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m2).
Deepcell Launches AI-Powered Single Cell Analysis Platform
Deepcell has announced the launch of the REM-I Platform, a high-dimensional cell morphology analysis and sorting platform which comprises the REM-I benchtop instrument, Human Foundation Model and Axon data suite.
Scribe Announces Collaboration To Accelerate In Vivo CRISPR-Based Genetic Medicines
Scribe Therapeutics Inc. has announced a strategic collaboration with Prevail Therapeutics, granting Prevail exclusive rights to Scribe’s CRISPR X-Editing technologies for the development of in vivo therapies directed to specified targets known to cause serious neurological and neuromuscular diseases.
Personalis, National Cancer Center Hospital East and Ono Collaborate To Better Predict Immunotherapy Response for Rectal Cancer
Personalis, Inc., National Cancer Center and Ono Pharmaceutical Co., Ltd. have announced they have entered into a collaborative agreement to examine the efficacy and safety of nivolumab, an immune checkpoint inhibitor, for resectable rectal cancer with mismatch repair deficiency.
Thermo Fisher Scientific Expands ImmunoCAP™ Test Availability Across US
Thermo Fisher Scientific has announced it is making ImmunoCAP™ Specific IgE tests available to more patients across the U.S.
Form Bio Announces AI Solution Set for Predicting and Optimizing Cell and Gene Therapy Manufacturability
Form Bio has announced the launch of FORMsightAI, a new, AI-based solution set for predicting and optimizing manufacturing outputs of cell and gene therapy constructs.